BCBS ‘Evidence Street’ Group Enabling Engagement With MDx Players

 In xifin news

Evidence Street, the Blue Cross Blue Shield Association’s web-based evidence review platform for medical products that’s been operational for around 15 months, is continuing to grow its influence within the diagnostics sector and among payors. Several molecular diagnostics companies, which as a sector generally cite reimbursement coverage as one of its biggest headaches, recently touted Evidence Street opinions on their tests as milestones.

Recent Posts
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.